PFAS and Alzheimer disease: The role of PFAS as hub of a molecular pathway disrupted in AD is further strengthened by the finding of extensive and significant overlaps between the subnetwork centred on PFAS and the KEGG AD pathway, as well as with curated sets of genes affected by transcriptional dysregulation at distinct stages of the disease (S5 Table and S11 Fig).